These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17366593)

  • 21. Clinical description of intracranial hemorrhage associated with bleeding disorders.
    González-Duarte A; García-Ramos GS; Valdés-Ferrer SI; Cantú-Brito C
    J Stroke Cerebrovasc Dis; 2008; 17(4):204-7. PubMed ID: 18589340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.
    Gattermann N
    Leuk Res; 2007 Dec; 31 Suppl 3():S10-5. PubMed ID: 18037413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
    Martin MG; Walgren RA; Procknow E; Uy GL; Stockerl-Goldstein K; Cashen AF; Westervelt P; Abboud CN; Kreisel F; Augustin K; Dipersio JF; Vij R
    Am J Hematol; 2009 Sep; 84(9):560-4. PubMed ID: 19650118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromes.
    Ferrero D; Darbesio A; Giai V; Genuardi M; Dellacasa CM; Sorasio R; Bertini M; Boccadoro M
    Br J Haematol; 2009 Feb; 144(3):342-9. PubMed ID: 19036104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The myelodysplastic syndrome and autoimmunity].
    Laursen SB; Nielsen MØ; Hasselbalch HC
    Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment strategies in myelodysplastic syndromes.
    Atallah E; Garcia-Manero G
    Cancer Invest; 2008 Mar; 26(2):208-16. PubMed ID: 18259954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A limited number of 5-azacitidine cycles can be effective treatment in MDS.
    Müller-Thomas C; Schuster T; Peschel C; Götze KS
    Ann Hematol; 2009 Mar; 88(3):213-9. PubMed ID: 18696067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
    Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
    Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic stem cell transplantation in patients with myelodysplastic syndrome: outcome analysis according to the International Prognostic Scoring System.
    Rubio S; Martins C; Lacerda JF; Carmo JA; Lourenço F; Lacerda JM
    Acta Med Port; 2006; 19(5):343-7. PubMed ID: 17376319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to manage lower-risk myelodysplastic syndromes.
    Sekeres MA
    Leukemia; 2012 Mar; 26(3):390-4. PubMed ID: 21904382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
    Slovak ML; O'Donnell M; Smith DD; Gaal K
    Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective platelet aggregation in myelodysplastic syndromes.
    Girtovitis FI; Ntaios G; Papadopoulos A; Ioannidis G; Makris PE
    Acta Haematol; 2007; 118(2):117-22. PubMed ID: 17726306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
    Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
    Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
    Strapatsas J; Barbulescu EC; Lauseker M; Kaivers J; Hildebrandt B; Nachtkamp K; Strupp C; Rudelius M; Haas R; Germing U
    Ann Hematol; 2021 Oct; 100(10):2575-2584. PubMed ID: 34324021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of myelodysplastic syndromes in the geriatric patient.
    Ritchie EK; Lachs MS
    Curr Hematol Malig Rep; 2009 Jan; 4(1):3-9. PubMed ID: 20425432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.